Mast cell activation syndrome, or MCAS, is a condition in which mast cells (a type of immune cell found throughout your body) release their chemical contents too easily, too often, or in response to triggers that wouldn’t normally cause a reaction. This can produce a wide range of symptoms across multiple organ systems, from skin flushing and hives to digestive problems, brain fog, and rapid heart rate. Because mast cells exist in nearly every tissue, the symptoms can look different from person to person, making MCAS notoriously difficult to pin down.
How Mast Cells Normally Work
Mast cells are part of your immune system’s first line of defense. They sit in tissues close to the outside world, like your skin, gut lining, and airways, waiting to detect threats. When they encounter something harmful, they “degranulate,” releasing hundreds of chemical mediators stored inside them. The best known of these is histamine, the same substance behind allergy symptoms like itching and swelling. But mast cells also release other signaling chemicals, including ones that attract more immune cells, widen blood vessels, trigger mucus production, and promote inflammation.
In a healthy immune response, this process is tightly controlled. In MCAS, that control breaks down. The mast cells themselves aren’t abnormal in number (which would be a different condition called mastocytosis), but they become hyperreactive. They fire off their chemical payloads in response to low-level stimuli, or sometimes without any identifiable trigger at all.
Symptoms Across Multiple Systems
Because mast cells live in tissues throughout the body, their overactivation can produce symptoms that seem unrelated to each other. This is one of the hallmarks of MCAS and one reason many people go years without a diagnosis. Common symptom clusters include:
- Skin: Flushing, hives, itching, and swelling. These are among the most recognizable signs because histamine’s effects on the skin are well understood.
- Digestive system: Abdominal cramping, nausea, diarrhea, bloating, and acid reflux. Many people with MCAS are initially diagnosed with irritable bowel syndrome.
- Cardiovascular: Rapid heart rate, low blood pressure, lightheadedness, and fainting episodes. Blood vessel dilation caused by mast cell mediators can drop blood pressure suddenly.
- Neurological: Brain fog, headaches, difficulty concentrating, and anxiety. Mast cells in the membranes surrounding the brain can activate pain pathways when they degranulate.
- Respiratory: Wheezing, nasal congestion, shortness of breath, and throat tightness.
Symptoms often come in flares. You might feel relatively fine for days or weeks, then experience a cascade of problems across several systems at once. In severe episodes, reactions can resemble anaphylaxis, with dangerous drops in blood pressure and difficulty breathing.
Common Triggers
People with MCAS often notice that specific exposures set off their symptoms, though the list of triggers varies widely from person to person. Heat, cold, physical exertion, and emotional stress are frequent offenders. Chemical exposures are another major category: fragrances, cleaning products, paint fumes, cigarette smoke, pesticides, new carpet or furniture, and volatile organic compounds from construction materials can all provoke reactions.
Food triggers are particularly frustrating because they can be inconsistent. Foods high in histamine or other biogenic amines are common culprits. Fermented foods (aged cheese, sauerkraut, soy sauce, wine), tomatoes, and alcohol tend to be problematic across the board. Alcohol is a double hit because it’s often high in histamine and also slows your body’s ability to break histamine down. Some people also react to dairy, wheat, eggs, caffeine, and food additives like MSG or artificial dyes.
One distinctive feature of MCAS is that a trigger tolerated one day may cause a reaction the next. This inconsistency makes it hard to identify patterns and can lead people (and their doctors) to question whether the reactions are real.
How MCAS Is Diagnosed
Diagnosing MCAS requires meeting three criteria: symptoms consistent with mast cell activation across two or more organ systems, laboratory evidence that mast cells are involved, and improvement with medications that block mast cell mediators.
The laboratory piece is the most technically challenging. The preferred test measures a blood protein called tryptase, which mast cells release when they degranulate. A blood sample drawn during or within one to four hours of a symptomatic episode is compared against your personal baseline. If the acute level rises by at least 20% above your baseline plus an additional 2 ng/mL, that’s considered strong evidence of mast cell activation. For example, if your baseline tryptase is 5 ng/mL, a reading above 8 ng/mL during symptoms would meet the threshold.
The problem is that getting blood drawn during an acute flare is logistically difficult. Urine tests offer an alternative. These measure breakdown products of histamine and other mast cell chemicals, and they can be collected as a 24-hour sample or a spot sample within about five hours of an episode. The main urinary markers include a histamine metabolite, a leukotriene metabolite, and a prostaglandin metabolite.
Two competing sets of diagnostic criteria exist, and they disagree on how strictly to interpret the lab requirements. The stricter criteria (sometimes called “consensus-1”) diagnose fewer patients, while the broader criteria (“consensus-2”) capture more. Some researchers estimate that MCAS could affect up to 17% of the general population under the broader definition, while the stricter approach identifies less than 5% of suspected patients. This disagreement is a major source of controversy in the field, and both approaches are currently considered valid.
The MCAS, POTS, and EDS Overlap
You may have seen MCAS mentioned alongside two other conditions: postural orthostatic tachycardia syndrome (POTS), a disorder of blood pressure and heart rate regulation, and hypermobile Ehlers-Danlos syndrome (hEDS), a connective tissue disorder causing joint hypermobility. Clinicians have noticed that these three conditions frequently appear together, and patients increasingly present with all three. One retrospective study found that 31% of patients with both POTS and EDS also met criteria for MCAS, compared to just 2% of patients without those conditions.
The relationship remains poorly understood, though. A detailed literature review found almost no original research examining a shared mechanism between the three, and the authors cautioned that the apparent overlap may stem from vague, subjective symptoms that are common across many conditions rather than from a true biological link. Whether or not the triad reflects a single underlying process, having one of these conditions is a reasonable prompt to consider the others if unexplained symptoms persist.
Treatment Approaches
Treatment for MCAS focuses on two goals: reducing the amount of chemical mediators your mast cells release and blocking the effects of those mediators on your tissues. Most people start with a combination of H1 and H2 antihistamines. H1 antihistamines (the kind commonly used for allergies) target symptoms like itching, hives, and flushing. H2 antihistamines, originally developed for acid reflux, address stomach symptoms and complement the H1 blockers. Taking both types together tends to work better than either alone.
A mast cell stabilizer called cromolyn sodium is another option. Rather than blocking the effects of mediators after release, it helps prevent mast cells from degranulating in the first place. It’s taken orally and primarily targets gut symptoms, since it isn’t well absorbed into the bloodstream. In clinical trials, second-generation H1 antihistamines have shown significant improvements in quality of life and symptom control for itching, flushing, rapid heart rate, and headache, though gastrointestinal symptoms sometimes require additional treatment.
Finding the right combination takes time. Many people with MCAS cycle through several medication adjustments before landing on a regimen that controls their symptoms, but the outlook is generally encouraging. Most patients eventually find a treatment combination that produces sustained improvement, regardless of how long they were symptomatic before diagnosis.
Dietary Strategies
A low-histamine diet is one of the most common self-management tools for MCAS, though it comes with important caveats. There’s no standardized food list, and the lists that circulate online vary widely, which creates confusion. Some foods are consistently flagged across sources: fermented products, aged cheeses, cured meats, fish that isn’t very fresh, soy sauce, tomatoes, and alcohol. Beyond those, individual tolerance varies enormously.
The typical approach is to eliminate high-histamine foods for two to four weeks, then gradually reintroduce them one at a time to map your personal triggers. Because the diet is nutritionally restrictive and socially limiting, working with a dietitian familiar with histamine intolerance helps avoid unnecessary restriction. It’s also impossible to eliminate histamine from your diet entirely, since it occurs naturally in many foods and increases as food ages. The goal isn’t zero histamine but rather keeping your total histamine load below the threshold that triggers your symptoms.